OSSDSIGN AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.75 SEK | +5.52% |
|
+4.39% | +21.88% |
| 04-15 | Certain Shares of OssDsign AB are subject to a Lock-Up Agreement Ending on 15-APR-2024. | CI |
| 04-02 | OssDsign Signs Three-year Supply Contract with Premier for Bone, Bone Substitute Products | MT |
| Sales 2023 | 112M 10.27M 820M | Sales 2024 * | 127M 11.65M 931M | Capitalization | 902M 82.62M 6.6B |
|---|---|---|---|---|---|
| Net income 2023 | -130M -11.9M -951M | Net income 2024 * | -59M -5.4M -432M | EV / Sales 2023 | 5.54 x |
| Net cash position 2023 | 160M 14.67M 1.17B | Net cash position 2024 * | 96.68M 8.85M 707M | EV / Sales 2024 * | 6.33 x |
| P/E ratio 2023 |
-5
x | P/E ratio 2024 * |
-15.1
x | Employees | 41 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 50.84% |
More Fundamentals
* Assessed data
More news
Latest transcript on OssDsign AB
More press releases
| 1 day | +7.47% | ||
| 1 week | +6.32% | ||
| Current month | -1.68% | ||
| 1 month | -3.97% | ||
| 3 months | +14.14% | ||
| 6 months | +64.40% | ||
| Current year | +24.12% |
1 week
8.96
10.24
1 month
8.9610.94
Current year
7.7810.94
1 year
4.5310.94
3 years
2.6110.94
5 years
2.6126.80
10 years
2.6126.80
| Managers | Title | Age | Since |
|---|---|---|---|
Morten Henneveld
CEO | Chief Executive Officer | 48 | 31/08/20 |
Anders Svensson
DFI | Director of Finance/CFO | 61 | 31/12/19 |
Kajsa Björklund
COO | Chief Operating Officer | 51 | 31/12/15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Simon Cartmell
CHM | Chairman | 64 | 19/04/16 |
Viktor Drvota
BRD | Director/Board Member | 59 | 31/12/14 |
Newton Aguiar
BRD | Director/Board Member | 60 | 31/12/18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 9.75 | +5.52% | 305 286 |
| 26/04/24 | 9.24 | -0.86% | 583,375 |
| 25/04/24 | 9.32 | +1.08% | 334,996 |
| 24/04/24 | 9.22 | +0.22% | 116,366 |
| 23/04/24 | 9.2 | -1.50% | 311,684 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 08:57 am
More quotes
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Calendar
14/05/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +24.12% | 82.3M | |
| +12.07% | 128B | |
| -8.63% | 10.65B | |
| +0.91% | 8.82B | |
| +16.72% | 7.19B | |
| +25.15% | 4.99B | |
| +7.17% | 3.4B | |
| -1.36% | 3.03B | |
| -8.73% | 2.14B | |
| -10.15% | 2B |
- Stock Market
- Equities
- OSSD Stock
